News from biocept, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 04, 2021, 08:05 ET Biocept to Present at H.C. Wainwright Virtual BioConnect Conference

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Dec 31, 2020, 17:29 ET Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Dec 30, 2020, 08:05 ET Biocept Enters into Laboratory Services Agreements with Two Southern California Regional Independent Physician Associations

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Dec 14, 2020, 08:00 ET Biocept Provides Business Update

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Dec 10, 2020, 08:00 ET Biocept's Target Selector™ Liquid Biopsy Demonstrated High Accuracy When Used for Monitoring the Progression of Metastatic Breast Cancer in Study Conducted at Johns Hopkins Sidney Kimmel Cancer Center

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Nov 20, 2020, 08:00 ET Study Shows Biocept's Assays are Viable and Sensitive for Detecting Tumor Cells and Biomarkers in the Cerebrospinal Fluid of Patients with Breast and Lung Cancer that has Metastasized to the Central Nervous System

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Nov 17, 2020, 08:05 ET Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS®

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Nov 12, 2020, 16:05 ET Biocept Reports Third Quarter 2020 Financial Results

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Nov 12, 2020, 08:05 ET Biocept Provides Update on COVID-19 Testing with More than 100,000 Samples Received

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer,...

Nov 09, 2020, 08:05 ET Biocept Receives Hong Kong Patent Covering the Enhanced Detection of Rare Cells, including Cancer Cells

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Nov 05, 2020, 08:05 ET Biocept Awarded Broad Japanese Patent for the Use of Binding Entities in Combination with any Solid Surface to Capture and Detect any Target of Interest, including CTCs, from any Sample Type

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests, products and services designed to provide physicians with...

Nov 04, 2020, 08:00 ET Biocept to Release Third Quarter 2020 Financial Results and Host Investor Conference Call on November 12, 2020

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients,...

Oct 29, 2020, 08:05 ET Biocept Provides Update on COVID-19 Testing with More than 80,000 Samples Received

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer,...

Oct 21, 2020, 08:00 ET Biocept Appoints Samuel D. Riccitelli to its Board of Directors

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services, announces the appointment of Samuel D....

Oct 06, 2020, 08:00 ET Biocept Provides Update on COVID-19 Testing with More than 50,000 Specimens Received

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating patients with cancer,...

Oct 05, 2020, 08:00 ET Study Shows Biocept's Target Selector™ May Provide a More Robust Method for Detecting Lung Cancer Metastasis in Cerebrospinal Fluid than Cytology

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients,...

Oct 01, 2020, 08:00 ET Biocept to Present Study Results from Target Selector™ Testing in the Cerebrospinal Fluid of Patients with Lung Cancer at the IASLC Liquid Biopsy Meeting

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with ...

Sep 23, 2020, 08:00 ET Biocept Announces the Award of Japanese Patent for Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations in Tissue, Blood and Cerebrospinal Fluid

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable...

Sep 21, 2020, 08:00 ET Biocept Announces that Highmark Has Made a Positive Coverage Determination on Target Selector™ Liquid Biopsy

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...

Sep 16, 2020, 08:00 ET Biocept Provides COVID-19 Testing Update with More than 35,000 Specimens Received

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...

Sep 09, 2020, 08:00 ET Biocept to Present at the H.C. Wainwright Global Investment Virtual Conference on September 14

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostics designed to provide physicians with clinically actionable...

Sep 08, 2020, 08:00 ET Biocept Executes In-Network Provider Agreement with Health Net Federal Services Extending Coverage for its Liquid Biopsy Oncology Platform to the TRICARE West Region Network

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...

Sep 04, 2020, 16:28 ET Biocept Announces One-for-Ten Reverse Stock Split

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...

Aug 31, 2020, 09:24 ET Biocept Provides COVID-19 Testing Update with More Than 21,000 COVID-19 Specimens Received and More than 20,000 Specimens Processed

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable...

Aug 27, 2020, 08:00 ET Biocept to Present at the LD Micro 500 Virtual Conference

Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable...